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ABSTRACT
Characterization of Antigen-Specific Antigen Processing by
The Resting B Cell
(March 1988)
Edmund J. Gosselin, B. A., University of New Hampshire
, University of New Hampshire
Ph. D. University of Massachusetts Medical School
Directed by: David C. Parker
An optimal antibody response to a thYmus-dependent
antigen requires cooperation between the B cell and an
antigen-specific helper T cell. Major histocompatibility
complex restriction of this interaction implies that the
helper T cell recognizes antigen on the B cell surface in
the context MHC molecules and that the antigen-
specific cell gets help acting ant igen
presenting cell for the helper T celi. However a number
of studies have shown that normal resting B cells are
ineffective as antigen presenting cells, implying that the
B cell must leave the resting state before it can interact
specifically with a helper T cell. On the contrary, other
studies including those using rabbit Ig as antigen , and
rabbi t globul in- speci f ic mouse cell lines and
hybr idomas , show that certain cell lines can
efficiently stimulated by normal resting B cells.
One possibility I considered was that small B cells
are unable to process antigens and that the rabbit Ig-
specific T cell lines used above recognize native antigen
the cell surface. the majority cases
experiments with B cell lines and macrophages have shown
that antigen presentation requires antigen processing, a
sequence events which includes : internalization
antigen into acid compartment, denaturation
digestion of antigen into fragments and the return of
processed antigen to the cell surface where it can then be
recognized by the T cell the context class
molecules of the MHC.
The experiments reported here show that the rabbit Ig-
specific T cell lines do require an antigen processing
step, and that small resting B cells , like other antigen
presenting cells, process antigen before presenting it to
T cells. Specifically, I show that an incubation of 2-8
hours is required after the antigen pulse before antigen
presentation becomes resistant to fixation or irradiation.
Shortly after the pulse, the antigen enters a pronase
resistant compartment. Chloroquine , which raises the pH
endocytic ves icles inhibi ts presentation 
addi tion, large excess of antibody to native antigen
fails to block presentation of antigen after a 2-8 hour
incubation. Al so al though membrane Ig, the antigen
receptor the cell, required for efficient
presentation of antigen at low concentrations , antigen is
no longer associated with the B cell receptor at the time
of presentation to the T cell. Modulation of membrane Ig
by anti-Ig blocks presentation before but not after the
antigen pulse.
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INTRODUCTION
B CELL-T CELL INTERACTION IN B CELL ACTIVATION
The humoral phase the immune response plays a
crucial role in the body' s defense against both intra- and
extracell ular pathogens. The key ingredient this
response is antibody, an antigen-specific protein which
once produced, can serve in numerous capacities to either
inactivate or destroy the infecting agent. In order for
antibody production to occur, a number of events must take
place. These events include antigen dependent activation
of B lYmphocytes specific for the pathogen and factor
dependent proliferation and differentiatiation of these
cells into antibody secreting plasma cells (1, 2).
The production of antibodies protein antigens has
been extensively studied and known invol ve
cooperati ve interactions between the lYmphocyte and
helper T lYmphocyte (3). However, the precise mechanism
by which this interaction occurs is still not thoroughly
understood, and continues generate questions and
controversy. While has been shown that some
instances the addition of T cell factors and antigen is
sufficient to induce B cell differentiation and antibody
secretion (4-6), it is generally thought that in the case
of the resting B cell , direct cell to cell contact between
the B cell and the T cell is necessary in order for B cell
activation to occur (3, 7).
Linked Recognition
Ini tial work suggesting that antibody production
invol ves interaction between two different cell
populations was provided in 1966 by Claman et ale ( 8 ) who
showed that mixtures of bone marrow cells and thYm
derived cells when inj ected with antigen into
irradiated syngeneic host produced better antibody
response than either population alone. This was supported
by other work which demonstrated complementation between
thymus and bone marrow cells in graft vS. host responses
(9) . In 1968 Miller and Mitchel went a step further
showing that antibody responses thYmectomized mice
could be reconstituted by adding back thymic lymphocytes
(10) . Using semiallogeneic thymus cells , they were also
able demonstrate that the cells responsible for
antibody production originated from the thYmectomized host
and not the donor thYm cell s (11) . This was
agreement with work by Davies et ale (12) which showed
that thymus cells were unable to produce antibody, while
bone marrow derived cells could. This lead to a proposal
by Claman and Chaperon in 1969 to explain the phenomenon
now termed "thYmus-marrow complementation" (13) . Called
- the "two cell theory of antibody production " this model
proposed that the thymus derived cell interacted with the
antigen, while the cells derived from bone marrow were the
antibody forming suggested that thiscells. was
interaction might involve direct cell-cell contact between
the thYmus cell and the antibody producing marrow cell.
In 1970 Raff (14) added further support to the "two cell
theory of antibody production" by confirming the existence
subpopulations fluoresceintwo lYmphocytes using
labeled antibodies specific for the theta antigen (now
called Thy 1), present on thYmus cells , and Ig, present on
antibody producing cells (ie: bone marrow cells) 
Mitchison (15) was the first to provide a tangible
model this transferinteraction. Usingfor adopti ve
techniques he showed that B cells primed to a given hapten
on one carrier would respond to the same hapten on another
carrier, providing a population of spleen cells primed to
the second carrier was provided. This carrier effect"
(16) could be eliminated if T cells were depleted from the
population of spleen cells primed to the second carrier
(17). These results led to the conclusion that the B cell
recognized the hapten and the T cell the carrier , that the
hapten-carrier complex formed a bridge between these two
cells (Fig. la), and that through this bridge the helper T
cell could deliver to the B cell the appropriate signals
required activation termfor cell (15 19) . The
"linked recognition" was coined to describe this process.
MHC Restriction
Allo eneic res onses. Prior to the discovery of B
cell-T cell interactions , it had been known for some time
that genetics played a significant role in the immune
response. Tissue transplanted from one to aindividual
genetically disimilar individual rapidwould resul t
rejection of the transplanted tissue (20). The cause of
rej ection appeared to be the presence number
serologically defined specificities present cell
membranes. The genetic source these specificities
could be mapped to the H-2 locus which complex locus
or group closely linked loci, currently referred
the major histocompatibility complex (MHC) (Fig. 2).
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Figure 1
Figure Models for B cell-T cell interaction.
Linked recogni ton. recognizecell and cellThe
separate determinants on the same antigen molecule.
the hapten-carrier cellconj ugate, thecase
receptor recognizes the hapten the T cell receptor the
carrier. The dual receptor model. The T cell has two
separate receptors; one which recognizes the antigen , the
other which recognizes Ia. The single receptor , dual
recognition model. The T cell has a single receptor for
both Ia and antigen, but Ia and antigen are recognized
separately on the B cell surface. Antigen processing.
Antigen binds to the B cell receptor, is internalized into
an acid compartment where it is processed, and is then
returned single cellthe cell surface where
receptor recognizes antigen and Ia as a molecular complex
on the presenting cell surface.
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Figure 2. Designations for I region genes in the maj or
histocompatibility region of the mouse. A depiction of
hoW our understanding the mouse ma j 0 r
histocompatibility complex changed from 1972-1987 (21-24).
In 1964 Bain et ale (25) provided some of the first in
vi tro evidence indicate genetics playthat may
significant regulation immune cellrole the
interactions. When leukocytes from different individuals
were mixed, a substantial in cell proliferationincrease
was observed. This was case when cells fromnot the
monozygotic twins were used. Referred to as the mixed-
lYmphocyte reaction or MLR this provided an in vitro
system for studying vivo H-2the phenomenon
dependent graft rej ection. Resul ts by Bain et ale were
later supported by studies using one-way mixed lYmphocyte
cultures in which one of the donor populations was treated
with mitomycin C to prevent proliferation (26). In 1966
Dutton provided convincing(27 ) the most data for
genetic link showing congenic micethat
proliferative response could only be obtained providing
there were differences at the H-2 locus. Differences at
weaker" histocompa tib il i ty loci did inducenot
proliferative response. Later studies suggested that it
was differences at the K end of the H-2 locus (Fig 2a)
which were responsible for the MLR (28). However , these
studies did not take into account differences in regions
between the H-2K and H-2D loci. It was subsequently
demonstrated that the true genetic source of MLR resided
in this, as yet , undefined region between H-2K and H-2D
(21, 29-31) . Because differences in this region could not
be easily detected serologically, whereas those in the H-
and H-2D regions lYmphocytecoul d , the terms
defined differences) , serologically definedand
differences) were applied , respectively, to describe these
loci (21).
Anti en-s ecific res onses. During this same period
number order tovivo studies showed that
restore antigen-specific immune function in thYmectomized
mice it was necessary to provide syngeneic thYmus cells
(11 32, 33) . suggested that rej ection donorIt was
tissue was responsible for the failure of allogeneic cells
to reconstitute the antigen-specific response. Kindred
and Shreffler, in 1972 , provided another explanation (34).
They suggested that immune responsiveness was not restored
by allogeneic cells due to the positive rather than the
negative histocompatibil i tyeffect cell-cell
interactions. They used nude mice which accept allogeneic
skin grafts (35-37). this case , only syngeneic thymus
grafts antibody response despite thecomplemented the
fact allogeneic rej ected.that grafts notwere
alternative approach to demonstrate the same phenomenon
was used by Katz et ale (38) . They inj ected parental
carrier primed T cells and DNP primed B cells into an
irradiated Fl hybrid host and measured subsequent antibody
responses. Responses were obtained only those
instances where both lymphocyte populations were derived
from the same parent (ie: where syngeneic populations were
used) . Because the strains used in these studies differed
in many areas besides the major histocompatibility locus
H-2, it was not possible to definitively conclude what
region of the genome was responsible for controlling B
cell-T cell interaction. To clarify this issue Katz et
al. (39) used congenic strains of mice which differ only
in the H-2 locus. These studies demonstrated conclusively
that a region in the H-2 locus was responsible for the
control of antigen-specific B cell-T cell interactions.
More detailed studies using inbred and recombinant strains
of mice differing at known locations of the H-2 complex
permi tted precise location of these genes , referred to as
CI or cell-interaction genes (40) , again to a region in
the H-2 complex between H-2K and H-2D (41).
Immune res onse enes . Concurrent with the above
work addi tional studies were being done on a related
phenomenon. Using am ino acid polYmers antigens
Benacerra f ale ( 42) showed that delayed type
hypersensitivity and antibody responses occurred in some,
but not all members of an outbred guinea pig population.
Use of two different strains of guinea pig definitively
showed that respons i venes these polymers was
genetically controlled. strain 2 guinea pigs were capable
of responding to DNP-PLL and to GL whereas strain 13 was
not. The Fl hybrid (2 X 13) could also respond suggesting
responsiveness was dominant. McDevitt made similar
observation mice (43 ) and later mapped the genes
controlling immune responsiveness (now termed Ir genes) to
an area between the H-2K and S region of the H-2 complex
(44) .
Unif theories. Al though the common location of
the LD, CI and Ir genes suggested a functional as well as
genetic link between the three, such a relationship was
not accepted in its entirety until the early 1980'
the mean time several theories were offered to explain
this apparent linkage.
In 1972 Benacerraf and McDevitt proposed that Ir genes
may code for a T cell receptor, separate and distinct from
immunoglobulin (45). A number of studies supported this
view (46 47) . Efforts show the presence
immunoglobulin on the surface of the T cell were largely
unsuccessful (46) . Yet by using antibodies derived by
reciprocal immunization of congenic mice differing in the
H-2K to S region of H-2 , directed against Ia antigens (the
apparent products the genes) , antigens were
localized on the T cell but not on bone marrow cells
(47) .
A number of additional studies soon contradicted the
latter results, and provided strong evidence against the
theory that Ir genes produce a T cell receptor. First it
was clearly demonstrated in 1974 that B cells , and not T
cells possessed the highest levels of Ia antigens on their
surface (48) . Functional studies by Katz et ale (49 )
prov ided further support for the view that gene
control, as well as Ir gene products are expressed by the
cell. Using adoptive trans fer they showed that
responses could only be obtained providing the B cell was
derived from a responder population. The above data
combined with that of Zinkernagel and Doherty (50) showing
that cytotoxic T cells see antigen in the context of class
I (H-2K , H-2D) , led to the proposal in 1975 and 1976 that
antigens may serve similar function acting
restriction elements for class II (Ia) mediated antigen
presentation (23, 51) . Subsequent studies strongly
supported this view. Sprent (52) showed that T cells
derived from congenic and recombinant strains of mice
proliferated in response to antigen only when B cells
sharing the end the H-2 complex were prov ided .
similar requirements for other presenting cells were also
observed (53) . addition, gene defects the
surface the macrophage (also an antigen presenting
cell) (54-56) or the B cell ( 49) could al ter T cell
responsiveness (57-59).
was primarily the acceptance that LD , CI and Ir
genes resided wi thin the same region of the MHC , the I
region (57) (Fig. 2a) , and the isola tion anti - Ia
antibodies (47, 60), in particular monoclonal antibodies
(61), that allowed researchers to conclusively demonstrate
that LD , CI and Ir genes were one in the same, and that
their product was the Ia antigen.
In 1976 Schwartz et ale (62) showed that anti-Ia anti-
sera (directed against differences in the I region of the
MHC) could block one-way MLR' s provided the antibody ' was
directed against the appropriate Ia antigen present on the
stimulator cells. Baxevani s ale (63) , 1980
provided evidence for identity between Ir genes and Ia
antigens. First , the presence of certain allelic forms of
Ia correlated wi immune respons i veness to particular
antigens. Second, responses which localized to different
areas within the I region were blocked by antibodies to
different allelic forms of Ia. studies in which it was
shown that monoclonal anti-Ia antibody could block
antigen-specific responses under Ir gene control , as well
as an MLR directed against the same determinant (64) ,
provided the strongest evidence for identity between the
three genes (LD , CI , and Ir) and their products.
confirmed by additional studies using T cell
This was
clones in
which the responses of antigen-specific and alloreactive
clones (responsive to, or restricted by the same allelic
form Ia) could blocked the same anti-Ia
monoclonal antibody (65). Further evidence for identity
between and determinants was provided
studies mutant (bmI2) . Al terations MLR
reactivity, Ir gene function, and restriction of antigen
presentation could be attributed to this mutation (66-68).
The Mechanics of MHC Restriction
Early studies by Mi tchison and others had suggested
that antigen alone served as a bridge to link the B and T
lymphocytes ( 15 , 16) . However the discovery MHC
restriction forced a serious re-evaluation of this model
and raised a number of very basic questions incl uding :
gene product regulating restriction , how 
his product and antigen recognized simultaneously by the
- T cell receptor, and how does MHC restriction regulate
Ia anti ens. As discussed above , the answer to the
question what the gene product regulating
estriction, appeared in a series of studies beginning in
973 with the isolation of alloantibodies directed against
By using genetic recombination and
it was subsequently demonstrated in
that the I region could be divided into five
and C (Fig. 2b) . Ia antigen
eterminants were associated with regions I-A
, I-E and I-C
The use of anti-Ia antibodies also facilited
,biochemical analysis of the Ia protein (22). By using
adiolabel ing techniques immunoprecipi tation and PAGE
the product the I-A subregion was
hown to be composed of two chains, alpha and beta , held
disulfide bonds (72), and weighing
pproximately 35, 000 and 30 000 daltons respectively (71).
the I-E/C subregion product 
was shown to contain an alpha
:nd j:eta chain ( 2 2 , 70 , 71 , 73) , however, these chains were
distinct from those produced by the I-A subregion (72 74-
76) . In addition weremultiple amino acid differences
observed between products of the same subregion (77). The
observation that the surface expression of the I-E gene
product was under the control of two genes (78) , one in
the I-A and one in the led to theI-E subregion (79)
conclusion that I-E beta was actually an I-A subregion
product. I-B was defined by phenomenon that could be
explained by complementation betweengene I-A and I-E
(80) , no I-C genes or gene products have been isolated
(81) , studies I-Jand 1984 suggested that the
determinant may be the product of genes residing outside
the MHC (82). Thus , MHC restriction appears to depend on
the surface expression of at least one I region molecule
consisting two polypeptides, alpha and beta
originating from either the I-A or I-A plus I-E subregions
of the major histocompatibility complex (Fig. 2c).
The T cell rece tor. Prior to characterization of Ia
antigens it was already apparent that in order for T cells
to be restricted by Ia and also to respond to antigen
they would have to recognize both proteins simultaneously
on the same presenting cell. Two major theories were
arrived at to explain this dual recognition of Ia and
by the T cell. The first "The Dual Receptor
proposed that the the T cell recognizes antigen
and independently The(Figs.(83-90) and lc) .
second, "The Single Receptor Model, " suggested that the T
cell recognizes single molecularantigen asand
(90-94 ) (Fig. currentId) . The bulk of the
evidence supports the latter model.
Kappler et ale (95) provided strong evidence against
the dual receptor model by showing that when two T cells
with different specificities for Ia and antigen were fused
(KLH+H-2 f OVA+H-2a
) ,
hybrids obtained whichwere
recognized parental combinations of Ia and antigen but
did not recognize cross-specificities OVA+H-2f or(ie:
KLH+H-2a
) .
Attempts acti vat ionblock cell
preincubation of T cells with soluble Ia or antigen were
unsuccessful addition, the maj or(96) . both
histocompatibility molecule and antigen must be in the
Same membrane to induce T cell responses (97-99). studies
have also shown that antigen fragments bind to Ia, binding
most avidly whichthose theirhaplotypes
presentation is restricted (100). Furthermore , Ia -antigen
conj ugates efficient beingfold000are more
presented in artificial membranes than equivalent amounts
of Ia and antigen added separately Also their(101) .
presentation can be blocked by the addition of peptides
which compete for the .same MHC binding site , but not for
the same T cell (100). In fact, recent X-ray analysis
class I clearly demonstrate that a potential
binding pocket does exist between the alpha and
class I polypeptide (102).
other studies which favor the single receptor model
include those showing the T cell receptor is composed of a
single molecular complex; the Ia and antigen binding site
consisting two polypeptide chains, alpha and beta
(103), and studies in which the specificity of a recipient
T cell clone was al tered to that of a donor cell by
transfer of the alpha and beta chain genes of the T cell
receptor (104).
Alternatively, has been suggested that the T cell
receptor may still be composed of two separate binding
sites for Ia and antigen; the alpha chain binding one
ligand , the beta chain the other. A recent study by Saito
and Germain (105) showing that transfecting a beta chain
gene into cell can al ter restriction could
interpreted as support for this model.
Determinant selection versus clonal deletion Theories
explain the role MHC restriction
nonresponsi veness ini tially appeared in press 1978.
first, Determin Selection, was proposed
Rosenthal ( 56) . This model suggested that the inability
certain antigens elicit immune respons e
certain strains is due to the failure of that antigen to
associate with MHC on the antigen presenting
The second model, Clonal Deletion , was proposed by
Schwartz, and suggested that nonresponsiveness to certain
antigens was due to tolerance induction , the deletion of T
cell clones specific for self antigen plus (106).
studies by Ishii et ale (107 108) supported the latter
hypothesis by showing that APC from nonresponder animals
can present antigen to T cells from responder populations.
Klein, in a review in 1984, provided an extensive list of
arguements and counter-arguements for both theories (109).
Al though both may play a role in nonresponsi veness, the
most compelling evidence has been provided recently, and
favor determinant selection. has been
demonstrated that cell recognition, and
nonresponsiveness do correlate with the ability of certain
peptides bind the appropriate MHC molecule
(100 110 111) .
Antigen Presenting Cells
The macro In 1965 Harris (112) observed that in
response antigen rabbi t spleen cell cultures
morphological uni ts macrophages surrounded
lymphocytes formed. postulated that these uni ts
promoted blast cell formation by the lYmphocytes. While
this sugges ted role for the macrophage antigen
presentation, Mosier (113) provided the first functional
evidence in 1967 , showing that antibody responses to sheep
red blood cells required both an adherent (macrophage) and
nonadherent population of cells. Subsequent experiments
showed that the nonadherent cells could further
subdivided into two populations (114-116) . This led
Mosier propose model which the macrophage
presented antigen to the T cell, which in turn presented
the antigen to the B cell.
The importance the macrophage antigen
presenting cell was further emphasized in 1973 when it was
demonstrated that T cell proliferation occurred only when
antigen pulsed macrophages were provided (117 118). This
led Rosenstreich and Rosenthal (117) to conclude that the
macrophage or monocyte was "the primary antigen-binding
cell for the induction of T lYmphocyte proliferation,
These studies and others showing that macrophages were
restricted in their ability to present antigen by Ir genes
and their products, (Ia antigens) (119-121), set the tone
into the early during the majorwhi ch time1980'
emphasis antigen presentation focused the
macrophage. This ' limited view of antigen presentation
culminated in 1979 study by Singer et ale (122)in a
which it was suggested that previous studies (123-126)
showing MHC restriction between the B cell and the T cell
were incorrect cellowing contamination these
preparations with macrophages. Singer et ale (122) went
on to demonstrate that the interaction between antigen
presenting cells (ie: the macrophage) and T cells was MHC
restricted while the interaction between B and T cells was
not.
The B cell. viewThe that the macrophage was the
primary antigen presenting cell the immune response
changed rapidly following the appearance number
studies 1981 and 1982 which it was shown that the
cell could also antigen presenting cellserve
(18,127-129) . Chesnut and Grey in 1981(127) , showed
that normal B cells could present rabbit anti-Ig to rabbit
- globulin-specific T cells. Jones and Janeway (18), also
1981, demonstrated that the cell could present
antigen, and showed that the presentation was MHC
restricted. They also suggested that the purpose of the
antigen presenting macrophage might be to activate T cells
prior to a T cell-B cell interaction. In 1982, Glimcher
et ale (129) published work in which it was demonstrated
that a number of B cell lymphomas could present antigen to
their antigen-specific T cells. Walker et ale (128)
confirmed these observations, while also showing that the
majority of monocytic and macrophage tumors tested could
not present because they lacked Ia. A large number of
subsequent studies confirmed the above observations that B
cells present antigen (1, 130 131).
Ini tial attempts to demonstrate antigen presentation
by normal inactivated B cells were not successful ( 132-
134 ) ow ing the sensitivity these cells
irradiation (135). T cell proliferation was often used as
an indicator of presentation and irradiated B cells were
routinely used when measuring T cell proliferation.
1984 Ashwell et ale (135) showed that when radiation
sensitivity was taken into account, normal B cells , both
small and large could present number antigens
- including GAT, Cytochrome c and hen egg lysozYme with
equal efficiency, to T cell lines and T cell hybridomas.
Frohman and Cowing (136), in 1985 , showed that lYmph node
primed B cells could also present antigen (KLH) to primed
cells. However upon comparing the efficiency
" - presentatio between macrophages LPS activated B cells
and small resting B cells , they observed that the latter
two were 4 and 1000 fold less efficient , respectively, at
presenting KLH. In contrast to this observation , Tony et
al. (137, 138) showed that resting B cells could present
nanogram levels of rabbit anti-Ig to rabbit Ig-specific T
cell lines.
other anti en resentin cells. Recent studies have
suggested that antigen presentation is not limited to the
B cell and the macrophage. other antigen presenting cells
include: the dendritic cell (139 140) , the endothel ial
cell (141-143), and most probably a number of additional
Ia bearing cells (131) . The primary requirement for
antigen presentation appears to be the presence of Ia on
the presenting cell surface. This most clearly
demonstrated in studies in which Ia and antigen are placed
lipid bilayer, and presentation observed
(144 145) . For most protein antigens , there appears to be
an additional requirement, antigen processing.
Antigen Processing
As originally understood, linked recognition implied
that the hapten-carr ier complex remained unal tered
following its initial binding to the B cell receptor, and
that both the T cell and the B cell recognized the native
antigen. wi thin the last ten years numerous studies have
suggested that this interpretation of linked recognition
is incorrect (131, 146-149). First , a revised model (Figs.
Ib and lc) was necessary to account for the fact that such
interactions are restricted only to those presenting cells
carrying the appropr iate cl ass molecul e the ir
surface (94 146). Second it has been shown that most B
cells primed to native antigen see only native antigen
while T cells, primed in a similar manner , respond to both
native and denatured antigen (150 151). Third studies
using macrophages as antigen presenting cells (APC) have
indicated that in order for the T cell to interact with Ia
and antigen on the macrophage surface , the antigen must be
processed (ie: internalized into acid compartment
structurally altered, and returned to the cell surface in
thQ context of class II where it can then be recognized by
the T cell) (152 , 153) . In addition numerous studies
using B cell lymphomas (154, 155) and antigen-specific EBV
transformed B cells (147) as APC have indicated that B
must also process antigen before presenting it to
lYmphocyte. This has led to the proposal of an
al ternati ve model explain the phenomenon of linked
recognition, which includes antigen processing (Fig. 1d).
In this model the recogni tion of antigen is sequential
rather than simul taneous and invol ves both native and
processed forms of the antigen. First the B cell receptor
recognizes the na ti antigen solution, then the
antigen is internalized, and is processed. The processed
antigen is then returned to the B cell surface were it is
recognized by the T cell in the context of MHC class II
molecules.
Despi te the overwhelming data in favor of processing,
. a number of researchers continue to provide evidence which
supports presentation of native antigen. Klein and Walden
(156 ) showed that native antigens such insul in and
ovalbumin could be presented when inserted into vesicles
containing class II. However, it has been argued that the
insertion of antigen into these vesicles denatures them
providing the equivalent of processing.
Ziegler (157) showed that large molecular weight
antigens can be presented by fixed presenting
cells, and that in the absence of fixation , chloroquine
which blocks presentation of many processed antigens , does
not block presentation of these antigens.
The most convincing ev idence for presentation
antigen however has been provided Allen'
laboratory. has shown that fibrinogen presented
its native form (158) fixed presenting
and that this presentation not chloroquine
This work enj oys considerable acceptance even
like Allen, who support the antigen processing
This primarily because fibrinogen contains
secondary structure in, the region recognized by
the T cell , and therefore may closely resemble denatured
or processed antigen in that region.
ANTIGEN-SPECIFIC ANTIGEN PRESENTATION
Experimental Models
optimal antibody response to a thYmus-dependent
requires cooperation between the B cell and the
lymphocyte specific for the same antigen
MHC restriction of this interaction impl ies
- that the helper T cell recognizes antigen on the B cell
surface in the context of the class II MHC molecules, and
that the antigen-specific B cell gets help by acting as an
antigen presenting cell for the helper T cell.
Due the clonal distribution cell
specifici ties, antigen-specific cells are rare, and
presentation these cells difficult study.
number methods have been used circumvent this
problem. These include the use of antigen-specific EBV
transformed B cell lines (147), purified antigen binding
cells (159), and rabbit anti-mouse Ig in place of antigen
(137, 138). The latter model, anti-Ig, provides
polyclonal antigen analogue which binds to all Ig+ B cells
regardless of their specificity. Initially, it provided a
model for studying cell activation direct
consequence of antigen binding (160). Chesnut and Grey
(127) extended its use to the study of T cell activation
by demonstrating that rabbit Ig-specific T cells would
respond to rabbit anti-mouse Ig initially bound to mouse B
cells. The isolation of rabbit Ig-specific T cell lines
by Tony and Parker in 1985 (138) has now made it possible
with this model (Fig. 3) , to study the full range of
events involved in T cell dependent B cell activation.
Figure 3
RABBIT ANTI-
ANTIGENIC FRAGMENT
CLASS II
Models for the presentation of rabbit anti-
resting B cells. (a) Antigen processing.
anti-mouse Ig binds to Ig on the surface of mouse B
The rabbit Ig is then internalized into an acid
processed and returned to the cell surface
presented in the context of class II. (b)
presentation of unprocessed antigen. Rabbit anti-mouse Ig
the mouse B cell and while still bound to
surface Ig, is presented to the T cell in the context of
class II.
Al though number studies have been done
demons tra te that ce II s are very efficient antigen
presenting cells for antigen initially bound to membrane
Ig (127, 137 138 147 161, 162), it is still unclear at what
stage in the activation pathway the B cell can present
antigen to the T cell in order to obtain T cell help.
Normal B Cells
Normal B cells are heterogeneous in size , RNA content,
surface molecule expression, and their ability to function
antibody responses. Thes e differences have been
interpreted as representing different states of activation
within the normal B cell population (7, 160). Despi te the
difficul ties of studying antigen presentation by normal
antigen- specif ic cells receptor-mediated antigen
presentation by the normal B cell has been demonstrated in
a number of experimental systems, including those using
macrophage depleted spleen cells (127), primed lYmPh node
B cells (161), and antigen-specific B cells isolated from
normal B cell populations (162) . In the latter system
antigen presentation has been shown to invol ve antigen
processing such that the antigen, although initially bound
. to membrane Ig, is no longer associated with the B cell
the time of presentation. Also, antigen
these cells helper cell line
in vigorous antibody production by the
B cells (163).
since all the above studies used normal B cell
popula tions, these studies also included activated
cells. Therefore, it is not possible to conclude at what
B cell activation B cells are able to present
Resting B Cells
The majority of small, resting B cells differ from B
cells in various states of activation (ie: normal B cell
populations), in their requirements for T cell help, and
their ability act antigen presenting ce II s
130 131) . Even when sensi ti vi ty to irradiation has
account , large differences in the ability
of resting versus activated B cells to act as antigen
presenting cells have been reported in some (136 164 165),
not all laboratories (135 137 138) . Thus the
to whether resting B cells or do not
present antigen in a fashion similar to that
of other presenting cells remains controversial.
Chestnut and Grey suggested 1981 that normal B
ells could present rabbit anti-Ig to rabbit Ig-specific T
.:_
ellS, but could not present normal rabbit globulin (127).
conclusion was later retracted, and it was suggested
contamination with large B cells, and/or activation
anti-Ig had been responsible for the presentation of
anti-Ig which was observed (132).
As previously discussed , in 1984 Ashwell et ale (135),
using antigens that bind nonspecifically to the B cell
surface, provided evidence not only that resting B cells
present antigen but that they do so as efficiently 
cells. addition they concluded that the
inability Chesnut and Grey to demonstrate
presentation by these cells was owing to the fact that
they had irradiated their presenting cells prior to the
addition of antigen.
Since Ashwell' paper 1984 , additional studies
Ig-specific and nonspecific antigens
to indicate that resting B cells do
not present antigen (131 164 165), or are very inefficient
(136) . In direct contrast to the latter
our laboratory has demonstrated that resting B
present rabbit globulins , both normal and anti-
specific , to our rabbit globulin-specific T cell
lines (138) . It therefore seems clear that at least in
case resting cells present antigen. The
question that remains is how?
One possible explanation I considered was that resting
are unable to process antigen (Fig. 3a), and that
cell lines which were isolated based on their
ability to induce B cell activation and differentiation in
the presence of rabbit globulin and resting B cells , may
well have been selected to see native rabbit Ig (Fig. 3b).
OBJECTIVE
The purpose of this study was to determine if resting
B cells are able to process antigen. Al though in most
studies , T cell clones see only processed antigen, it is
not clear that processing prerequisi te for
presentation of all antigens to all T cells (157, 158 166).
In addition , processing of receptor-bound antigen had not
thoroughly characterized normal B cells which
could be clearly defined as resting.
The use of size-selected small B cells and the anti-Ig
model circumvents the problem of using B cell preparations
contaminated with activated B cells. This method provides
a polyclonal system for studying antigen processing and
presentation by B cells which can be clearly defined as
. resting.
I report here that small resting B cells are able to
process antigen.
MATERIALS AND METHODS
REAGENTS
Rabbit Fab' and F(ab' ) 2 anti-mouse IgM , F(ab' ) 2 anti-
mouse IgD , F (ab' ) 2 anti -mouse Fab , and F (ab' ) 2 NRG , which
W'ere used as antigens in these studies were made by
myself and technicians our laboratory , and were
obtained previously described (137, 167) . Affinity
purified F(ab' ) 2 goat anti-mouse Ig and affinity purified
F(ab' ) 2 goat anti-rabbit Ig were purchased from Jackson
Immunoresearch Laboratories Inc. (Avondale, PAw ) . The
monoclonal rat anti-IgM antibody (b-7-6) (168) was a gift
of Lyn Schmidt (U. Mass. Medical Center, Worcester , MA.
Antibodies used in T cell depletion were obtained
previously described (137 169). Heavy and light chains of
rabbit Ig were a gift of Dr. Thomas Kindt (NIH). Normal
rabbit globulins of known allotype were a gift of Dr. Rose
Mage (NIH). The cell line producing M5/114. 15. (an anti-
Ia antibody) was obtained from the American Type Culture
Collection (Rockville MD. ) , and was isolated
previously described (170 171).
from Sigma.
Chloroquine was purchased
B CELLS
A20 (172) and LID are H-2d B cell lYmphomas and were
obtained from Laur ie Glimcher (Harvard Sch. Publ .
Hl th. ) . Unless otherwise indicated, small B cells were
obtained from the spleens of C3D2 (C3HjHeJ X DBAj2J) Fl , (H-
2k X H-2d) mice (Jackson Laboratory, Bar Harbor, ME.
some instances CBAjN X A. BY (H-2k X H-2b) mice (Jackson
Laboratory, Bar Harbor , ME. ) were used. Spleen cells were
depleted of cells using cocktail monoclonal
antibodies (137 169): mouse anti-Thy 1. (HO-13-4) , rat
anti-Thy 1 (Jlj . 10), rat anti-Lyt-2 (3. 168. 8), rat anti-
L3T4 (GK 1. 5 . 6) , and mouse anti-rat kappa (MA 18. 5) .
Subsequent the addition the above antibodies
agarose absorbed guinea pig complement (Pel-Freez Brown
Deer WI. ) was added. Small resting cell s were
separated from activated B cells and other kinds of spleen
cells by counterflow centrifugal elutriation (138). size
profiles of these cell populations were determined with a
Coul ter Counter and Channelyzer (Coulter Electronics
Woburn, MA. ) (Fig. 4).
Figure 4
X Sll8J fO 
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Figure 4 . size cells isolatedprofiles
centri fugal elutriation. first peakThe
represents small B cells the second peak (- 
- - - - --)
small and large cells which remain after collection of the
intial small cell fraction.
the
B cells were obtained from
spleen cells depleted of T cells prior to elutriation.
T CELLS
DO 54. 8 was a gift of Howard Grey and is an H-2d
restricted , OVA-specific T cell hybridoma (154). DID was
obta ined from the American Type Cul ture Collection
(Rockville, MD. ) and conalbumin-specific H-2k
restricted helper T cell line. DID is alloreactive to H-
Two rabbit globulin-specific T cell lines were used
in these studies , CDC25 and CDC35 . These T cell lines
were isolated by David Parker in our laboratory and were
maintained by myself and technicians. CDC25 is H-2k/d
restricted (i t responds antigen antigen
presenting cells but not on APC of either parent) and
CDC35 is H-2d restricted. The isolation and maintainance
of these lines described elsewhere (137 138) .
brief, antigen-specific cells were establ ished from
lymph node cells of C3D2 mice primed in vivo with F(ab'
NRG and boosted in vitro wi th 100 pg/ml F ( ab' ) NRG.
Lines were established by limiting dilution at 100 input
cells/well. T cells were tested for their ability to
support F (ab' ) 2 anti-Ig dependent B cell proliferation
and secretion. Active cells were ma intained
restimulation of 6 X 104 T cells with 2 X 106 irradiated
spleen cells per ml of medium, plus 100 pg/ml of F(ab'
from rat spleen Con A supernatant. Al though
it was initially reported that these cell lines secrete
IL-2, we have since found that these T cell lines make IL-
and detectable IL-2 (173, and our unpubl ished
resul ts) .
CELL CULTURES
I set up cultures containing B and T lYmphocytes in 96
well, half area, flat-bottomed plates (Costar no. 3696).
Each well contained 5 X 104 B cells and 1 X 104 T cells
in 100 pl of RPMI 1640 (GIBCO Laboratories , Grand Island
NY) , containing mercaptoethanol gl utamine
penicillin , streptomycin, gentamycin and 10% FBS. B cells
were either pretreated with antigen or antigen was added
directly each well. Subsequently, cultures were
incubated at 37 C for 24 hours. Supernatants were then
collected and assayed for lymphokine content as a measure
of the T cell activation resulting from presentation of
antigen.
LYMPHOKINE ASSAY
To each full area well (Costar no. 3598) containing 50
pl of supernatant , I added 100 l of RPMI 1640 containing
1 X 104 IL-2/IL-4 dependent T cells (CTLL-2). Cul tures
were then incubated at 370C for 24 hours. 3H thYmidine ( 
uci/well , ci/mmole, MA. )New England Nuclear, Boston,
was added for an additional six hours , at which time the
cells were harvested onto glass fiber filters and washed
with water before liquid scintillation counting.
FIXATION
order fix cells prior to presentation I used
a modification of procedures by Shimonkevitz et ale (154).
Cells were washed twice with HBSS (no FBS) and resuspended
in the same to a final concentration of 5 X 106 cells/mI.
An equal volume of 0. 1% glutaraldehyde Sigma)(Grade I,
was then added for 30 seconds followed by an equal volume
L-lysine (Sigma). Cells were then washed with
HBSS (no FBS) and HBSS (1. 0% FBS), and resuspended in RPMI
1640 , with additions , to a final concentration of 1 X 106
cells/ml.
PRONASE TREATMENT
antigen with again usedpronaseremove
modification of methods originally used by Chesnut et. ale
(155) . Three milliliter samples of cells at 1 X 106
cells/ml washed once wi th RPMI 1640 (no FBS) andwere
resuspended finalgivethe same
concentration of 6 X 106 cells/ml. To each sample of
cells 50 pl (Type XIV, Sigma) dissol vedof pronase
double distilled wa ter , and 5 pl of DNase (Grade II
Boehringer Mannheim GmbH) dissolved in HBSS ( 1. 0 FBS)
were added to give final concentrations of 1. 0 mg/ml and
10 pg/ml respectively. Cells were then incubated for 30
minutes at 37 C and the reactions stopped by the addition
of 0. 5 ml of 100% FBS. Cells were then washed once in
HBSS (1. and resuspendedFBS) RPMI 1640
concentration of 1 X 106 cells/ml.
FACS ANALYSIS
Fl uorescence staining was carried out as previously
described (137). B cells were adjusted to 1 X 106/ml in
PBS containing 1. 0% FBS and 0. 1% sodium azide. Cells were
then incubated for 30 minutes at 40C with the appropriate
fluorescein saturatingconj ugated antibody
concentration. fixed.The cells were then washed and
Flow cytometry was performed by technicians in the flow
cytometry facility Medical Center)(U. Ma s s .
fluorescence activated cell 440 (Becton-sorter (FACS)
Dickinson Immunocytometry Systems , Mountain View , CA.
RESULTS
A PROCESSING INTERVAL IS REQUIRED PRIOR TO PRESENTATION OF
RABBIT IG BY THE RESTING B CELL.
Previous studies with presenting cells other than the
resting B cell have shown that antigen presentation can be
blocked the presenting cells are fixed before
immediately after addition of antigen. The same cells
will present if fixed following a 370C incubation after
antigen addition (155). Irradiation has been shown to have
a similar effect on normal B lYmphocytes (161) . Using
these same methods I wanted to determine if there is a
processing time requ ired before resting cells can
present rabbit Ig to our T cell lines. Fixation studies
in which B cell lymphoma cells were incubated for varying
amounts of time with antigen , at 37oC , followed by removal
of the antigen and immediate fixation suggested that a
processing time for rabbit Ig was required by CDC35 prior
to presentation (Table 1) . also showed that the
processing time for rabbit Ig was similar to that of OVA
between 4 and 20 hours (Table 1). Similarly fixation
TABLE 1
processing Kinetics of Rabbit Ig by B cell LYmphomas
B Cell A20 LID
Antigen
Time None anti- NRG OVA None anti- NRG OVA
(h) IgM IgM
250 285 315 283 329 317 338 225
466 258 299 329 261 372 325
394 3757 2519 1026 221 1698 799 1137
20. 509 8558 13198 20863 255 5704 8464 10388
a B cells were adjusted to 1 X 106 cells/ml and incubated
with either no antigen, 10 pg/ml F(ab' )2 anti-IgM
mg/ml F ( ab ' ) 2 NRG, or 1. 0 mg/ml OVA. Cells were incubated
for 0. 5, 2 , 4 , or 20 hours at 370C in HRPMI 1640 at which
time antigen was washed away and the cells were fixed.
and T cells CDC35 or DO 54. , were then put in culture
and lYmphokine secretion measured.
and irradiation (2000 rad) of small B cells implied a
requirement for processing by both T cell lines (CDC25 and
CDC35 ) If B cells were treated at time 0(Table 2).
(immediately after the 4 C antigen pulse), presentation
was blocked , but if they were treated following an 8 hour
incubation with antigen, presentation was observed
(Table 2).
(Table 2).
Fab' and F(ab' ) 2 anti-Ig gave similar results
Al though irradiation routinely reduced overall
responses by 1/3 to 1/2 (Fig. 5), irradiation appeared to
be the more sensitive method giving higher responses with
equivalent doses of antigen (Table 2). Additional studies
using only irradiation, in which antigen was washed away
immediately after a 30 minute 40C pulse in the presence of
1% sodium azide, indicated that the minimal time needed
to obtain presentation was actually between 2 and 4 hours,
and variety antigens incl uding nonspecificthat
F ( ab' ) NRG, receptor-specific rabbitand a number of
globulins: anti-Fab, anti-IgDF(ab' F(ab' ) 2 F ( ab' ) 
anti-IgM, anti-IgM produced similar results (Fig.Fab'
5) .
These experiments also showed somewhat longer
processing time requirement by CDC25 for rabbit anti-IgM
F (ab' ) 2 NRG , and a consistent reduction in the level
TABLE 2
use of Fixation Versus Irradiation in Measuring Processing
Kinetics of Small B Cells
FixationTreatment Irradiation
Antigen (pg/ml)
Time F ( ab' ) Fab'(h) (0) (0. (1.0) (0. (1.
CDC25
362 8212 11169 4651 11058
423 725 589 640 455
315 1564 4169 718 2266
268 1081 4949 1089 2195
F ( ab' ) F ab '(0. 1) (1. 0) (0. 1) (1.
415 528 1410
7531 9724 7360 7860
7622 9840 6945 8429
CDC35
638 6550 9820 2610 8253
299 696 276 785 409 571 639 481 383
286 766 570 502 407 4745 7034 5946 5659
334 584 707 781 402 2890 7370 3671 5226
a B cells were pulsed in RPMI 1640 for 30 minutes at 40C
with varying doses of antigen, then incubated at 370C
still in the presence of antigen. At 0, 8 or 20 hours of
incubation the antigen was washed away and the cells were
resuspended in RPMI 1640 to a final concentration of 1 X
106 cellsjml. After the wash cells were divided into
three groups. The first group remained untreated the
second group was fixed , and the third group was irradiated
with 2000 rad ( from cesium source) . Immediately
following treatment T cells were added and lYmphokine
secretion measured.
b Untreated.
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Figure 5. Processing kinetics of receptor-specific and
nonspecific rabbit Ig. Resting B cells were pulsed in
RPMI 1640 (0. 1% sodium azide) for 30 minutes at 40C with
F (ab' ) 2 anti-Fab , F (ab' ) 2 anti-IgM or F (ab' ) 2 anti-IgD 
and b), or (c) F(ab' )2 anti-IgM , Fab' anti-IgM or F(ab'
NRG. Cells in figures 5a and 5b were pulsed with 0.
pg/ml figure)(top figure)1. 0 pg/ml (bottom
antigen. In figure 5c cells recieved 1. 0 )lg/ml of antigen
except in the case of F (ab' ) 2 NRG which was added at 1.
mg/ml. Immediately after the pulse antigen and azide
were washed away and the cells incubated in RPMI 1640 at
37oC. At 0 , 2, 4 , 8, 12 or 20 hours of incubation , cells
were irradiated wi followingImmediatelyrad.2000
irradiation T cells , CDC25 (a and c) or CDC35 (b), were
added. Lymphokine secretion was measured 24 hours after
addition of T cells.
of presentation after incubations of 12 or 20 hours at
A substantial increase in the level of presentation
by resting B cells irradiated at time 0 could be obtained
by increasing the dose of antigen (Fig. 5a).
To determine if presentation of antigen by irradiated
cells at 4 and 8 hours might be due to the induction of
radioresistance the antigen resting cells were
pre incubated with goat anti-Ig (1. 0 pgjml) for 8 hours at
This did not alter the susceptibility of resting B
to irradiation at time 0 (Table 3), indicating that
in the case of receptor-specif ic antigen, presentation
and hours was not due induction
radioresistance by the antigen.
THE RELEVANT ANTIGEN IS INTERNALIZED.
It is generally believed that processing takes place
inside the presenting cell. Thus, native antigen once
bound to the presenting cell, should be susceptible to
pronase digestion unless it is internalized. Once ins ide
the cell , antigen should be protected from pronase.
order to determine if the rabbit Ig is inside the resting
cell during processing, cells were pulsed at 4oC
TABLE 3
The effect of Receptor Crosslinking on the
Radiosensitivity of Small B Cells
Untreated Goat Anti-IgM
Antigen
(Ag)(pg/ml) Ag-)oIrr. Irr. -)oAg Ag-)o Irr . Irr. -)oAg
336 493 305 220
9560 355 9837 532
24372 10423 21887 11106
1.0 25909 19371 18077 19316
cells were divided into two groups. One group
mained untreated while the other was pulsed with 1.
goat anti-IgM as described in figure At the end
minutes antigen and azide were washed away and the
cells were incubated for 8 hours at 37oC. Each group of B
cells was further divided half and one half was
irradiated immediately with 2000 rad while the other was
not irradiated until the completion of an 8 hour, 370C
incubation with antigen (Rabbit F ( ab' ) anti-Fab) .
cells were placed in 96 well plates immediately following
irradiation, T cells (CDC35) were then added, and, in the
case of unpulsed cells, antigen.
";",-'
the antigen was washed away, and the cells were treated
with pronase at varying times during a 370C incubation to
remove surface bound antigen (155). In instances where B
cells were pulsed with low doses of antigen treatment
with immediately 40C reducedafter the pul sepronase
presentation as much as 80%, with the level of inhibition
gradually decreasing to 0% by 2-4 hours (Fig. 6). These
data that majority relevant nativethesuggest
antigen , is inside the cell and protected from pronase by
2 -4 hours.
also considered for pronaseexplanationanother
resistance. It might be that processing itself alters the
susceptibili ty antigen orderpronase.
distinguish this possibility from that of internalization
pulsed B cells were treated with pronase at 2 4 or 
hours irradiated at 8 hours to preventand were then
further processing. Diminished responses were observed at
and This processedhours. resul t suggests that
antigen on the cell surface can be removed by pronase , and
that irradiation processed antigenaddi tionalprevents
from reaching the cell surface.
The level of inhibition by pronase treatment alone , or
by, irrradiation and treatment at 8 hours waspronase
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Figure Antigen internalization by small B cells
detected by susceptibility to pronase. Resting B cells
were pulsed , as in figure 5 , with rabbit F(ab' ) 2 anti-Fab:
Cells (topfigure 6a were pulsed with 01 )lg/ml
figure) or 0 . 1 pg/ml (bottom figure) of antigen.
figure 6b cells received 0. 1 pg/ml (top figure) or 1 . 0
pg/ml (bottom figure) of antigen. While still at 4oC , the
antigen was washed away. Ei ther immediately, or at 0.
2, 4, or 8 hours of a 370C incubation, the pulsed B cells
were trea ted with 370C incubationand thepronase
continued for the remainder of 8 hours. One half of each
cell sample was irradiated with 2000 rad at the end of 8
hours to stop further processing. T cells, CDC25 (a) and
CDC35 (b). , lymphokine secretionthen added andwere
monitored . In the absence of antigen , untreated B cells
induced a background response of 1 247 counts ( a) and
185 counts (b) which were not subtracted.
subtantially reduced at higher doses of antigen (Fig. 6).
While pronase treatment and irradiation , both at 8 hours
el iminates the response of T cells to small cells pulsed
with low doses of antigen, use of a ten fold higher dose
of antigen restores the response to a level equivalent to
or higher than that of small cells treated with pronase at
two hours (Fig. One possible explanation for this6) .
could be the failure , in some instances , of irradiation to
prevent processing at the higher doses (Fig. 5a) combined
with the failure of pronase to to totally remove antigen
also at these doses (Fig. 7a). The inhibitory effect of
pronase at low doses of antigen does not appear to be due
to an alteration of Ia on the B cell surface, or to the
failure of irradiated B cells to replace altered Ia or
some other required for presentation.surface molecule
Pronase treatment backgroundal though lowered
staining, did not alter the ability of an Ia-specific
antibody to bind to Ia (Fig. 7b), or the ability of an
allospecific T cell clone to respond to alloantigen on
irradiated presenting cells (Fig. 7c).
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Figure 7. The effect of pronase treatment on Ia and
antigen. Small B cells were divided in half , and one half
was treated with pronase following a 30 minute , 40C pulse
with 1 . 0 ).g/ml anti-FabF(ab' ) 2 ( a) the total
absence of an antigen pulse (b and c). B cell s were then
stained for rabbit Ig or (b) using fluorescein( a)
conj ugated anti -rabbit rat anti-Iagoat
respectivily. The effect of pronase on the response of an
alloreactive T cell line (DID) was also measured (c) by
moni toring lYmphokine secretion following the addition of
T cells to plates containing pronase treated or untreated
CBA/N X A. BY (H-2k X H-2b) B cells.
PRESENTATION IS CHLOROQUINE SENSITIVE.
To determine if the antigen , once internalized, enters
an acid chloroquine lysomotropic agentcompartment
which raises lysosomal pH, was used to block processing.
To do this experiment I used a method similar to that used
Chesnut ale (155) which was shown that
chloroquine did inhibit the presentation processed
antigen cell lYmphomas. this case, resting
cells treated with during hourchloroquinewere
antigen pulse. antigen and chloroquine were thenThe
washed away and T cells were added. To be certain that
inhibi tion ow ing irreversible damagenotwas
chloroquine to the presenting B cell, antigen was added
back to duplicate samples. At concentrations of O. 02mM 
07mM chloroquine, of antigen which do notand doses
induce maximal responses inhibition of presentation by
chloroquine was observed (Fig. 8).
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Inhibi tion of presentation by chloroquine.
Resting B cells (1 X 106 cellsjml) were incubated for 30
minutes at 370C in the presence of 0. 02 ro (upper figure)
(lower figure) chloroquine (Sigma) in RPMI
1640. Rabbit anti-Fab was then added , and the incubation
continued for 4 hours. Both antigen and chloroquine were
then washed away and the cells resuspended in RPMI 1640.
and T cells were then added in duplicate to 96 well
plates. To one set of plates antigen was added back.
Cul tures were then incubated and lYmphokine secretion
measured.
NATIVE ANTIGEN IS NOT PRESENTED.
determine native antigen is being presented
affinity purified goat antibody against native rabbit Ig
was added to cultures containing pulsed B cells 30 minutes
prior to the addition of T cells. If native rabbit Ig is
being presented to the T cells , one would expect the goat
anti rabbit Ig to bind and block presentation to the T
cell (174) . Up to a 3000 fold excess of the blocking
antibody did not inhibit presentation (Fig. 9).
since the presentation of rabbit Ig to our T cells is
paticularly sensitive to fixation (Table 3), and previous
studies using B cell lYmphomas fixation and OVA as
antigen have shown that the T cell lYmphoma DO 54. 8 can
respond to digested, but not intact OVA on the fixed B
cell , I decided to use this system to test whether our T
cell lines respond to native rabbit Ig on the surface of
the antigen presenting B cell lYmphoma. Attempts
induce antigen presentation on fixed B cells using native
rabbit Ig were not successful despite the fact the same
fixed B cells did present a tryptic digest of OVA to the
OVA-specific T cell hybrid DO 54. Our T cell line
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Figure 9. The Failure of goat anti-rabbit Ig to block
presentation of rabbit globulin. Resting B cells were
pulsed for 30 minutes at 40C with F(ab' ) 2 rabbit anti-Fab
37oC.figure incubated 8 hours atand then
Following this incubation, and 30 minutes prior to the
addition of T cells , B cells were put into 96 well plates
and 30ugjml of F(ab' )2 goat anti-rabbit Ig were added to
each Subsequently, werecells added andwell.
lYmphokine secretion measured.
CDC35, also failed to respond to the tryptic digest , but
did respond to antigen on fixed B cells if fixation was
preceded by an antigen pulse and C incubation for 
hours (Table 4).
Attempts to isolate a digest which could be recognized
by our T cell lines on fixed B cells was not successful.
However, it was possible, using heavy and light chains
and different allotypes of rabbit Ig, to determine that
CDC35 recognizes a site within the light chain constant
region of rabbit Ig. CDC35 failed to respond to purified
heavy chain, but did respond to purified light chains.
CDC25 appeared to respond to both (Fig. 10). This latter
observation might also be due to contamination of light
chains with chain sinceheavy showedCDC25 strong
preference for the latter. Both CDC25 and CDC35 detected
changes sequence within chainthe heavy variable
regions and the light chain constant regions respectively
of rabbit Ig as indicated by their reduced responses to
one of several rabbit Ig allotypes which differ between
each other only in these regions (175, 176) (Table 5).
TABLE 4
The effect of fixation on presentation of native antigen
Fixative 05% Glut. 017% Glut.
T Cell DO 54. CDC35 DO 54. CDC35
Treatment
Antigen (OVA) (NRG) (OVA) (NRG )
Unf ixed None 806 479
Native 39973 22402
Postf ixed None 252 326 459 491
Native 8395 12788 6777 15441
Prefixed Native 468 685 767 508
Digestb 3913 790 8952 663
a A20 B cell lYmphomas were incubated for 20 hours at 37
either in the presence (1. 0 mg/ml) or absence of antigen.
fixed with 017%cells were then either 05%
glutaraldehyde as described in materials and methods.
Tryptic digests andNRG OVA preparedwere
previously described (154).
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The specificity of T cell lines for the heavy
and light chains of rabbit Ig. B cells , T cells and heavy
light chains of rabbit Ig were combined in 96 well
The ability of our T cell lines to recognize
these antigens was measured assaying subsequent
lymphokine secretion.
TABLE 5
The response of T cell lines to different rabbit Ig
allotypes
Antigen Dose g/ml)
T Cell Allotype 500 250 125
CDC25 al/l b4/4
a2/2 b4/4 2309
5321 3141 2185
7714 3058
a3/3 b4/4 6427 1142 946
CDC35 a2/2 b4/4 5728 568 347
a2/2 b5/5 4774 340 190
a2/2 b6/6 3105 133
a2/2 b9/9 568 113
a B and T cells were plated as indicated in materials and
methods. The antigen was then added and subsequent
lymphokine secretion measured.
ANTIGEN IS NOT BOUND TO THE B CELL RECEPTOR AT THE TIME OF
PRESENTATION.
determine B cellantigen bound the
receptor at the time of presentation the receptor was
removed from the B cell surface with goat anti-Fab either
before or after the antigen pulse. If the antigen is
bound to membrane Ig at the time of presentation the
latter treatment receptorwithshould theremove
eliminating presentation (147 162). Addition of 30 pgjml
of goat anti-mouse Fab before the antigen pulse eliminated
presentation of rabbit anti-IgM (Fig. 11). This was not
the case if goat anti-Fab antibody was added after the
pulse. failure el imina teanti-FabThe goat
presentation after the pul se was not owing steric
interf erence rabbit anti-IgM (the antigen), since
flourescence staining did not demonstrate binding
competition between these two antibodies (Fig. 12).
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Figure 11. The failure of goat anti-mouse Fab to block
the presentation of rabbit anti-mouse IgM following the
antigen pulse. B cells were divided into two groups. One
group of resting B cells was pre-incubated for 30 minutes
at 370C with F(ab' ) 2 goat anti-mouse Fab (30 ,ugjml); the
other group received no goat antibody. Subsequently, each
group was pulsed with F(ab' )2 rabbit anti-IgM as described
in figure Following an 8 hour incubation at 3 7oC, the
group which had not been preincubated with goat anti-Fab
was further divided into two groups. One received goat
anti-Fab , the other did not. Cells were then incubated an
additional 30 minutes at 37oC, T cells were added and
levels of lYmphokine secretion determined.
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Figure 12. The lack of binding competition between goat
anti-mouse Fab and rabbit anti-mouse IgM. To B cells in
RPMI 1640 plus 0. 1% sodium azide, 0 pg/ml of F(ab'
rabbit anti-mouse IgM was added for 30 minutes at 4oC.
The rabbit antibody was then washed away with HBSS plus
1% sodium azide, and the cells resuspended in RPMI 1640
(0. 1% sodium azide). 30 pg/ml of goat anti-mouse Fab was
then added for 30 minutes at 4oC, the cells were washed
and were then stained with fluorescein conjugated anti-
goat Ig as described in materials and methods.
DISCUSSION
ANTIGEN PRESENTATION IN B CELL ACTIVATION
In order to produce antigen-specific antibody to a
thymus-dependent antigen the B cell must first be able to
function as an antigen-specific antigen presenting cell
for the helper T lymphocyte. Evidence that this can occur
has been provided by in vitro studies in which it has been
shown that B cells' from number of sources including
macrophage-depleted spleen cells (127), primed lYmPh node
B cells Epstein Barr virus transformed B cells(161) ,
(147), normal antigen-specific B cells (162), and in our
laboratory, size-selected small cells (137 138),
present antigen very efficiently when initially
bound to the B cell receptor. In addition, it has also
been demonstrated that presentation by normal B cells can
lead to a vigorous antibody response (137 138 163) .
the outset of this study" however , it was unclear at what
stage in B cell activation the B cell can present antigen
in order to receive T cell help.
THE ANTIGEN PRESENTING B CELL
Normal B Cells
Normal B cells represent a diverse population of cells
which vary in a number of incl uding size andrespects
state of activation. studies by Abbas et ale (162, 163)
using antigen-specific B cells isolated from normal B cell
populations have clearly demonstrated that these cells do
function very efficiently as antigen presenting cells, and
that this presentation does lead to the production of
antigen-specific addition, cellsantibody. these
process antigen, as indicated by a number of criteria.
First , normal antigen-specific B cells fixed or irradiated
prior antigen fail present antigen.pul sethe
Second, antigen intially bound to membrane Ig is no longer
bound to the B cell receptor at the time of presentation.
This suggests that presentation by the normal antigen-
specific B cell is sequential rather than simul taneous.
Antigen binds to the B cell receptor, is processed, and
then is presented to the T cell in the context of class II
MHO molecules , but is no longer associated with the B cell
receptor.
Resting B Cells
Recent studies have suggested that in order for the B
cell to present antigen to the T cell, the B cell must
first be activated (131 136, 164 165). This implies that
cognate interaction between the B cell and the T cell , and
the del i very help, cannot with thecell occur
majority population of small, resting B cells until those
cells become activated by antigen, bystander effects, or
some other signal (131).
In prior studies using rabbit Ig as antigen and rabbit
Ig-specific T cell lines, it appeared that size-selected
small cells capable cognate interactionwere
(137 138) . To explain this , I considered the possibility
that resting generally processunablecells are
antigens, rabbi t Ig-specific cellsthat theand
recognize native antigen bound to receptor Ig on the B
cell surface. Processing of receptor bound antigen by the
resting B cell had not been previously characterized in
normal B cells which could be clearly defined as resting.
While Abbas et ale (162) had shown that purified , hapten-
specific and present hapten-carriercells process
conjugates carrier-specific T antigen-cells these
specific B cells were obtained from the entire splenic B
cell population, and so included large B cells that were
activated in vivo. Also, these cells were isolated based
on the ability of their receptors to bind antigen and
could have been activated during the isolation procedure.
Use of size-selected small B cells and rabbit anti-Ig as a
polyclonal antigen analog circumvents this problem and
allowed me to show that small resting B cells do process
antigen.
Processing by small B cells appears to be very similar
to that of other antigen presenting cells in that antigen
must bind acidinternalized intothe cell,
compartment, in aand be returned to the cell surface
modified form, which can then be recognized by the T cell
in the context of MHC class II molecules.
Using the observation that antigen processing requires
an intitial period of incubation at 37oC, and that, in B
cells , processing is more radiosensi ti ve than presentation
of processed antigen (135, 162), I have shown that receptor
mediated antigen processing in small B cells takes between
2 and 4 hours after an antigen pulse , with presentation
reaching a maximum by 4 to 8 hours (Fig. 5).
Antigen processing appears to be the rate-limiting
step in antigen presentation. Previously, it was observed
that divalent F(ab' ) 2 fragments of anti-Ig were presented
at the same rate as monovalent Fab' fragments, as measured
by the onset . of lYmphokine secretion at 10 to 12 hours
(137), even though the divalent form of anti-Ig is capped
and endocytosed few minutes whi le much the
monovalent antibody persists Qn the cell surface for at
least an hour (177). In these studies observed no
difference antigen processing betweenratethe
divalent and monovalent antigen measured at 4 hours (Fig.
5c) . The rapid endocytosis of capped antigen does not
accelerate processing under the conditions we used, and
monovalent antigen appears enter rate that
saturates processing However, thepa thway.the
observation anti-IgD morepresentedthat F ( ab' ) 
rapidly to CDC25 than F(ab' ) 2 anti-IgM (Fig. 5a) and the
fact that there are higher levels of IgD versus IgM on the
B cell surface (160) could indicate that antigen dose is
rate limiting. Alternatively, antigen bound to surface
IgD may follow a different pathway than antigen bound to
IgM, and/or there may be greater difficulty in processing
anti-IgM for mul tiple passages(ie: needthere
through the processing pathway). In fact CDC35, which
responds to different determinant on rabbit globulin
than CDC25 (Fig. 10) did not detect any differences in
processing time between antigen bound to IgD and IgM (Fig.
5b) . This implies that the determinant CDC35 sees is more
easily processed than the determinant seen by CDC25 when
bound surface consistentThe reductionIgM.
presentation by to 20 hours of incubation (Fig.
suggests that once processed antigen reaches the surface
it remains for as little as 4 hours before being lost to
further processing surroundingthe medium. This
conclusion is in basic agreement with observations by Buus
et ale (101) that the half-life of antigen bound to Ia at
370C is between 5 and 10 hours.
The observation that presentation could still occur at
higher doses of antigen despite irradiation at time
(immediately after antigen binding) (Fig. 5a) could have a
number of explanations. It might be that in the presence
large antigenamounts antigen stillenough
processed by small to stillcells allow presentation.
Alternatively there small numbermay
radioresistant large cells which require the higher doses
of antigen in order to present. cannot exclude the
latter possibility. However, based the
radiosensitivity of presentation by my small B cells at
the lower antigen doses , and the observation that anti-Ig
does not induce radioresistance by 8 hours in these cells
(Table 3) , it seems clear that at the lower antigen doses
I am looking at processing and presentation by resting B
cells.
addi tion 2-8 hours forrequirementthe
processing, internalization also appears to be part of the
processing pathway. This is based on the observation that
antigen pulsed cells are able to present antigen following
pronase treatment at 4, or 8 hours of incubation, but
not if treated with pronase immediately after the pulse
when all the antigen would still be on the cell surface
(Fig. 6). However, if processed antigen is resistant to
pronase then processing could be occuring on the cell
surface. To test this idea , I divided treatment groups in
two and irradiated one set of samples at 8 hours to stop
further processing. This eliminated three fourths of the
cell to presenting B cells which had beenresponse
treated with pronase just before irradiation (Fig. 6) .
This result implies that processed antigen is sensitive to
pronase and that reexpression of internalized antigen
which occurs over an extended period of time , is sensitive
to irradiation. Alternatively, small B cells treated with
pronase and irradiated at 8 hours do present antigen when
the antigen dose is increased (Fig. 6a) . There are a
number of possible reasons for this. Pronase fails to
totally remove the antigen at higher doses (Fig. 7a), and
irradiation does not totally inhibit presentation , also at
these doses (F ig . 6a). Thus, presentation, in this case,
may due antigen still andwhich processed
presented despite these treatments. The observation that
B cells irradiated and treated with pronase at 8 hours
still rabbitpresent also suggests that thecan
machinery necessary for presentation (other than antigen)
is still intact. As has been shown previously (155) ,
fluorescence staining of pronase treated cells with anti-
Ia antibody indicates that pronase does not effect the
level of class II expression on the B cell surface (Fig.
7b) . This is consistent with the idea that the effect of
pronase treatment not due removal class
molecules. importantPronase some othermay remove
molecule from the B cell reexpression issurface whose
radiosensi ti ve. found that irradiated,However,
pronase-treated small B cells were just as effective as
irradiated, untreated cells in stimulating an alloreactive
T cell line (Fig. 7c).
Further support for processing comes from a number of
addi tional observations: inhibi tion presentation
chloroquine, failure cells recognizethe our
native antigen, and the observation that the antigen is
not bound the cell receptor timethe
presentation.
Chloroquine is a weak base which, in its unprotonated
form can penetrate the membranes of acidic compartments.
Once inside compartments, chloroquine becomesthese
protonated. In this form it longer pass throughcan no
membranes and (178) . The builduptrapped
chloroquine inside acidic compartments increases the pH
(179) and presumably alters the activity of pH-dependent
enzYm which may be involved in processing. Chloroquine
also has a number of other effects on cells including:
changes ul trastructural morphology of intracellular
ves icl es inhibiton endocytosis (180, 181) ,(178) ,
inhibition of receptor recycling (182, 183), and inhibition
of class II processing (ie: Ii no longer dissociates from
class II) (184). However, all of these effects may still
be the indirect result of raising lysosomal pH. Thus,
despite the additional effects of chloroquine treatment
the inhibition of presentation I have observed does add
further support the contention rabbitthat
internalized prior to presentation. It also implies that
acidic compartments are important to processing of antigen
the resting addi tion, antigen addedcell.
subsequent chloroquine presented,treatment
indicating that inhibition is reversible and requires the
presence of chloroquine during the antigen pulse (Fig. 8).
Our T cells do not appear to recognize native antigen.
They not respond na ti fixed cellNRG
lYmphomas (Table 4), or to rabbit anti-Ig on small B cells
fixed immediately after the addition of antigen (Table '2) .
I f our T cells did see native antigen on- the B cell
surface, then antibody against native rabbit Ig should
block presentation attempts block(174) . Such
presentation were unsuccessful (Fig. 9). Finally, antigen
is not attached to the B cell receptor at the time of
presentation. Anti-mouse which sufficientIg, removes
amounts of the B cell receptor to prevent presentation
when added before the antigen blockpulse cannot
presentation of an equivalent amount of antigen when added
after the pulse (Fig. 11).
number questions still remain regarding
processing by these and other antigen presenting cells.
studies processing appl ies intracellular
trafficking antigen have not been done.and
Specifically, we still are not certain that antigen meets
Ia inside the presenting cell. Also uncertain is whether
antigen is presented on recycled or newly synthesized Ia.
Unanue ale (177, 185) did carry out ultrastructural
studies of antigen internalization in the early 1970' s
but this was prior to the discovery of MHC restriction.
cresswell has provided some indirect evidence that Ia and
antigen inside showing thatthe cell (186 )meet
neuriminidase, transferrin, cl ea veswhen attached
sialic acids on both Ia and Ii fOllowing internalization.
In regards to the question of whether antigen binds to
recycled or newly synthesized Ia, pernis has suggested
that Ia and antigen are internalized simultaneously after
antigen binding ins ide themeetand subsequently
presenting B cell (187). However, this evidence is still
considered preliminary by most researchers and confirming
evidence has not been forthcoming.
Using ultrastructural methods (ie: colloidal gold and
electron microscopy), I plan to address these questions in
a more direct manner by following antigen and Ia into the
presenting B cell and labeling both simultaneously in the
same cell to determine where they go and if they enter the
same organelles.
The failure by others to demonstrate presentation by
the resting possiblecell have numbermay
explanations. By "small resting B we mean thecells" ,
maj ori ty population of small B lymphocytes in the spleens
mice. avoid large rcontamination withour
lYmphocytes and other cell types, I typically take only 10
to 20% of the total number of T-depleted spleen cells.
since physical andsmall cells have both theour
functional characteristics cellsresting
(7, 138, 160, 167, 188), and Fig. 4, I was not interested in a
minority population of very small or very dense B cells
which may be deficient in antigen presentation. Despi te
the fact our cells are resting at the time of isolation,
Hans-Peter our consideredlaboratory theTony
possibility that the presentation we see may be owing to
the activated eithercells duepresence
contamination with small numbers of large cells or to
activation by antigen or nonspecific signals delivered by
the T cells or present in the medium. since our T cell
lines basis to antigenrespond as well on a per cell
presented small large s pI een cells (189 )
contamination large cell s cannot account for the
activity of our small cell population. Activating signals
delivered antigen the cells cu 1 ture
condi tions prior to cognate interaction were also shown
not to be necessary, since preincubation of small B cells
with T cells but without antigen or in medium alone does
not kinetics oncelYmphokine productional ter the
antigen and T cells are present together (189).
Small cells may present some antigens but not others.
Rabbit anti-Ig binds directly to the B cell receptor and
is presented very efficiently (127 137 138). In the case
antigens which bind nonspecifically to cellthe
surface, the ability of individual antigens to bind to the
surface of the resting B cell may vary depending on their
structure. Some antigens may bind poorly or not at all
even at high concentrations (190). Alternatively, T cells
may be heterogeneous in their ability to see antigen on
resting B cells because of a need for an accessory cell
function not provided by resting B cells (135) or because
of fine specificity differences in their antigen receptors
which may detect differences in class II molecules or
processed antigen between resting and activated B cells
(136, 191) .
Despi te fail ure demonstratethe others
presentation by the resting B cell, it is clear from these
studies that the resting B cell is capable of processing
and presenting antigen to a helper T lYmphocyte without
prior activation. This is consistent with the suggestion
by Kishimoto (192) that the T cell secreted lYmphokine IL-
4 acts primarily on the resting B cell , and implies that
the interaction between the resting B cell and the helper
lYmPhocyte may provide tbe initial signal in B cell
activation.
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